Skip to main content
. 2011 Dec 1;184(11):1247–1253. doi: 10.1164/rccm.201103-0514OC

TABLE 3.

CAUSES OF TREATMENT FAILURES IN AFRICAN AMERICANS AND WHITES IN ACRN STUDIES

African American (n = 46) White (n = 101)
Reason N (%) N (%) P Value
Asthma exacerbation 21 (45.7) 61 (60.4) 0.1091
Use of inhaled, oral, parental steroids for increased asthma symptoms 20 (43.5) 60 (59.4) 0.0776
Emergency treatment or hospitalization at a medical facility for an acute asthma exacerbation 5 (10.9) 6 (5.9) 0.3205
Decreased lung function (defined as 20% fall in FEV1 from baseline or a 35% fall in peak expiratory flow from baseline on two of three consecutive [twice daily] measurements) 7 (15.2) 23 (22.8) 0.3791
Increased asthma rescue medication use (defined as use of 8 puffs per 24 h over baseline use for a period of 48 h, or ≥ 16 puffs per 24 h for 48 h) 32 (69.6) 47 (46.5) 0.0123*
Physician clinical judgment for safety reasons 16 (34.8) 50 (49.5) 0.1098

Definition of abbreviation: ACRN = Asthma Clinical Research Network.

Data are not mutually exclusive. Each individual treatment failure could have been attributable to more than one reason.

*

P value < 0.05, Fisher exact test.